FDA Inspection
Hovione FarmaCiencia SAHovione FarmaCiencia SA – FDA Inspection, May 18, 2018
Record Details
This FDA Inspection record concerns Hovione FarmaCiencia SA, with an inspection on May 18, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- Person
- Yvesna C. Blaise (Issuing Officer)
View Company Profile
ID · 2cee1a51-0636-40a9-ac62-bd23f821b9ae
Inspection Facts
- Inspection number
- 1056585
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Hovione FarmaCiencia SA
13| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2024 | Not classified | Office of Inspections and Investigations | |
| June 28, 2024 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| March 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hovione FarmaCiencia SA
- FDA Inspection 1281614 - 2024-10-24
- FDA Inspection 1243996 - 2024-06-28
- FDA Inspection 1200271 - 2023-03-10
- FDA Inspection 1203729 - 2021-11-12
- FDA Inspection 1037736 - 2017-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.